Henry Han

GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis cmacahilig@crf.org Fri, 02/06/2026 - 16:50 L.A. McKeown Those with preserved EF seemed to get more protection against HF events/CV death than those with reduced or unknown EF.

GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF (UPDATED) The effect size was modest, but the glycoside improved clinical outcomes when added to GDMT.

Adding digitoxin to contemporary GDMT improves clinical outcomes in patients who have HFrEF, according to results from the DIGIT-HF trial. Read more here:
#ESCCongress2025 www.tctmd.com/news/digitox...

Starting SGLT2 Inhibitors in the Hospital for Acute HF Gains Support Starting SGLT2 Inhibitors in the Hospital for Acute HF Gains Support cmacahilig@crf.org Sat, 08/30/2025 - 09:08 Todd Neale DAPA ACT HF – TIMI 68 missed its primary endpoint, but experts say the totality of the evidence backs early use of the drugs.

Starting SGLT2 Inhibitors in the Hospital for Acute HF Gains Support

#ESCGuidelines on #Myocarditis & #Pericarditis🫀

📍umbrella term: Inflammatory Myopericardial Syndrome used until diagnosis is clarified
📍Emphasizes use of #whyCMR
📍Clear recommendation for #EMB
📍Genetic & inherited CMPs highlighted🧬

🔗: doi.org/10.1093/eurhea…
#ESCCongress @escardio.bsky.social

The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology

onlinejcf.com/article/S107...
@drmarthagulati.bsky.social @dranulala.bsky.social @jcardfail.bsky.social

Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the #HFA of the ESC

@escardio.bsky.social onlinelibrary.wiley.com/doi/10.1002/...

@vietheartpa.bsky.social @anastasiasmihaili.bsky.social @cardioobdoc.bsky.social @erinmichos.bsky.social

Cardiologists More Often Send Higher-Risk Patients for CAC Scans vs Generalists Cardiologists More Often Send Higher-Risk Patients for CAC Scans vs Generalists cmacahilig@crf.org Tue, 07/29/2025 - 16:42 Yael L. Maxwell The decade-long, single-healthcare-system study gives insights into how physicians are using CAC tests and in which patients.

Cardiologists More Often Send Higher-Risk Patients for CAC Scans vs Generalists

Unraveling the link between birth order and blood pressure: insights from a comprehensive systematic review and meta-analysis The objective of the present systematic review was to incorporate previous studies investigating the association of birth order with the risk of systo…

Large #MetaAnalysis finds no significant difference in systolic or diastolic #BloodPressure between firstborns and later-borns. #BirthOrder may not affect blood pressure levels after all. #Epidemiology #PublicHealth www.sciencedirect.com/org/science/...

Conduction system pacing: promoting the physiology to prevent HF

Background and Clinical perspectives of HBP and LBBP area in HF
link.springer.com/article/10.1...

#HF #CardioSky #CardioEd @cardioobdoc.bsky.social @drrajivsankar.bsky.social @annakatebarton.bsky.social @vietheartpa.bsky.social

Financial Toxicity: An Overlooked Driver of Heart Failure Risk in the USA Heart failure is responsible not only for high morbidity and mortality, but also for significant out-of-pocket expenses for patients...

Financial Toxicity: An Overlooked Driver of #HeartFailure Risk in the USA

www.emjreviews.com/cardiology/a... #EMJCardiology

@cardioobdoc.bsky.social @erinmichos.bsky.social @joyywu.bsky.social @anastasiasmihaili.bsky.social @vietheartpa.bsky.social

The invisible costs of heart failure: a societal toll

academic.oup.com/eurheartj/ad...

@escardio.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @erinmichos.bsky.social @drmarthagulati.bsky.social

The impact of federal actions on academic medicine and the U.S. health care system

www.aamc.org/about-us/aam...

@cardioobdoc.bsky.social @arghavansallesmd.medsky.social @erinmichos.bsky.social @drmarthagulati.bsky.social

🚀 Want to stay updated with the latest from #EHJCVI and #EHJIMP? 📷 Follow our amazing Social Media Editors! 📷
@EHJCVIEiC & @EHJIMPEiC, our Editors-in-Chief bringing the latest to your feed! @escardio.bsky.social @jgrapsa.bsky.social @hancardiomd.bsky.social

Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis AbstractBackground and Aims. Colchicine has emerged as a safe and inexpensive anti-inflammatory medication to target the residual risk of cardiovascular ev

Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis

@escardio.bsky.social @cardioobdoc.bsky.social @pnatarajanmd.bsky.social @drmarthagulati.bsky.social @erinmichos.bsky.social @mmamas1973.bsky.social
academic.oup.com/eurheartj/ad...

Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis

#Colchicine significantly reduced #MACE in patients with vascular disease: pooled HR 0.75 (95% CI 0.56–0.93) across 6 RCTs (n=21,800).

#CardioSky @escardio.bsky.social

Proposed NIH budget cut threatens ‘massive destruction of American science’ A leaked draft of a Trump administration proposal includes an approximately 40 percent cut to the National Institutes of Health’s budget and a major reorganization of its 27 institutes and centers.

This damage will be irreparable. www.thetransmitter.org/funding/prop...

Evolution of Critical Care Cardiology: An Update on Structure, Care Delivery, Training, and Research Paradigms: A Scientific Statement From the American Heart Association:

Evolution of Critical Care Cardiology: A Scientific Statement From the American Heart Association

www.jacc.org/doi/10.1016/... @jaccjournals.bsky.social @mmamas1973.bsky.social @mirvz.bsky.social @cardioobdoc.bsky.social @thanhneville.medsky.social @drmarthagulati.bsky.social

Evolution of Critical Care Cardiology: An Update on Structure, Care Delivery, Training, and Research Paradigms: A Scientific Statement From the American Heart Association

#CCU #CICU #JACC #CardioSky @jaccjournals.bsky.social @americanheart.bsky.social @accintouch.bsky.social

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says Once-daily orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with diabetes and obesity.

Once-daily #orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with #DM and #obesity

@tctmd.bsky.social @mmamas1973.bsky.social @cardioobdoc.bsky.social
www.tctmd.com/news/oral-gl...

Phase 3 trial of PO #Orforglipron ; lowering A1C by an average of 1.3% to 1.6% across doses

Once-daily oral pill reduced weight by an average 16.0 lbs (7.9%) at the highest dose in a key S’ endpoint

@tctmd.bsky.social @mmamas1973.bsky.social @shelleyzieroth.bsky.social @drmarthagulati.bsky.social

Gaps and Knowledge in the Contemporary Management of Acute Right Ventricular Failure

www.ahajournals.org/doi/10.1161/...

@ahascience.bsky.social #RVFailure #HeartFailure #CardioEd @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @mmamas1973.bsky.social @mirvz.bsky.social

Shared Mechanisms in Cancer and Cardiovascular Disease: S100A8/9 and the NLRP3 Inflammasome: JACC: CardioOncology State-of-the-Art Review

www.jacc.org/doi/10.1016/...

#Cancer and #CVD are intertwined, with inflammation and a dysregulated immune system being common contributors

Shared Mechanisms in Cancer and #CVD : #S100A8/9 and the #NLRP3 #Inflammasome

#CardioSky #OncoSky @cardioobdoc.bsky.social @novitham.bsky.social @pnatarajanmd.bsky.social

This study aimed to characterize HF with supranormal EF (HFsnEF) using different LVEF cutoffs (35%, 55%, and 70% for men, and 40%, 60%, and 75% for women).
onlinelibrary.wiley.com/doi/full/10....
@escardio.bsky.social @hvanspall.bsky.social @erinmichos.bsky.social @docbhardwaj.bsky.social

Clinical and plasma proteomic characterization of heart failure with supranormal left ventricular ejection fraction: An emerging entity of heart failure

#EJHF @escardio.bsky.social
#CardioSky @shelleyzieroth.bsky.social @jimjanuzzi.bsky.social @drmarthagulati.bsky.social @cardioobdoc.bsky.social

#Aldosterone-targeted therapies: early implementation in resistant #HTN and #CKD

Reflecting on the fundamentals and exploring future directions

academic.oup.com/eurheartj/ad...
#CardioSky @escardio.bsky.social #EHJ @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social

Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial Finerenone and glycaemic status in patients with heart failure with mildly reduced/preserved ejection fraction. CI, confidence interval; CV, cardiovascular; HF, heart failure; HR, hazard ratio; RR, r...

#Finerenone reduced the risk of CV death and total worsening HF events, and was well-tolerated, independent of glycaemic status in HFmrEF/HFpEF

@escardio.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social @docbhardwaj.bsky.social

onlinelibrary.wiley.com/doi/full/10....

#Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the #FINEARTS-HF trial

onlinelibrary.wiley.com/doi/full/10.... @escardio.bsky.social #CardioSky @

#Aldosterone-targeted therapies: early implementation in resistant #HTN and #CKD

Reflecting on the fundamentals and exploring future directions

academic.oup.com/eurheartj/ad...
#CardioSky @escardio.bsky.social #EHJ @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social

Dr. Shirlee Song presents sex differences in #stroke #WIHD25
🧠 many sex disparities in the Tx of stroke:⬆️ disability b/c less tx
🧠 fewer studies in 💃🏻
🧠 cerebral ischemia may not be same in women🆚 men
🧠 women have more stable plaques & ⬆️ Sx risk
@womensheart.bsky.social @smidtheart.bsky.social